Abstract

Pseudomonas aeruginosa is an important cause of nosocomial infections worldwide. Worryingly, many 'P. aeruginosa' are multidrug -resistant, and the carbapenem-resistant 'P. aeruginosa' have been recognised as a global threat by the World Health Organisation (WHO).A prevalent international clone of 'P. aeruginosa' is ST235, which is associated with high-level antibiotic resistance and poor clinical outcomes. We report an isolate of ST235 'P. aeruginosa' harbouring IMP-26, which to the best of our knowledge is the first case of in New Zealand, in a patient with no history of overseas travel.

view journal